SynthesisVeterinary medicine and science2025
Lumpy Skin Disease in Cattle and Buffalo in Asian Countries: A Systematic Review and Meta-Analysis.
Synthesis in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Lumpy Skin Disease in Cattle and Buffalo in Asian Countries: A Systematic Review and Meta-Analysis.Veterinary medicine and science · 2025Pooled it
- Farmers' knowledge, attitudes, and practices regarding lumpy skin disease in Northern Bangladesh.BMC veterinary research · 2026Article
- Uttarkashi-strain based goatpox vaccine provides inadequate protection against lumpy skin disease in cattle.Veterinary research communications · 2026Article
- Prevalence and Serotype Distribution of Foot and Mouth Disease (FMD) Virus in Asian Countries: A Systematic Review and Meta-Analysis.Veterinary medicine international · 2026Review
- Prevalence and Antimicrobial Resistance Profiles of Enterococci Isolated From Humans, Animals, and Environment in Bangladesh: A Systematic Review and Meta-Analysis.International journal of microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLumpy skin disease (LSD) is an acute viral transboundary disease of cattle and buffalo with significant economic importance caused by the LSD virus in the Poxviridae family.
objectiveThis study aimed to determine the regional prevalence of LSD in cattle and buffalo in Asian countries using a systematic approach.
methodsA systematic search for articles on the prevalence of LSD in cattle and buffalo was performed via PubMed, Web of Science, Scopus, Google Scholar, and article reference lists published between 1 January, 2012 and 28 February, 2025. Articles were selected according to the established inclusion and exclusion criteria. The pooled prevalence was estimated through a random effects meta-analysis model because significant heterogeneity existed among the studies.
resultsThe overall pooled estimated prevalence of LSD in Asia was 25.2% (95% CI: 95% CI: 19.95-30.88%), with significant variations across species, countries, and diagnostic methods. Cattle had the highest pooled prevalence at 26.2% (95% CI: 20.73-31.96%), whereas buffalo reported much lower rates at 7.7% (95% CI: 3.60-13.00%), and epidemic cases presented the highest prevalence at 41.4% (95% CI: 0-98.1%). Temporal analysis revealed that the peak prevalence in 2016 was 74% (95% CI: 68.56-79.06%), and the lowest estimate in 2015 was 16.3% (95% CI: 3.25-36.47%).
conclusionThis study reveals significant regional and species-based variations in LSD prevalence across Asia, with diagnostic methods and temporal trends influencing the results. These findings underscore the necessity for targeted surveillance and control strategies to address high-prevalence areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.